Under Eye Fillers

The under-eye area is one of the most technically demanding injection zones on the face. We address this directly because "undereye filler gone wrong" is a real search patients make — and the fears behind it deserve honest answers.

What is the Tyndall effect? The Tyndall effect is a blue or grey discoloration that appears when HA filler is placed too close to the skin surface. The thin, translucent undereye skin allows light to scatter off the filler gel, producing the visible color change. It is not dangerous, but it is cosmetically undesirable. ↗

How we minimize the risk:

• Product selection: Volbella XC's low viscosity reduces the risk compared to thicker fillers
• Cannula technique: A blunt-tipped cannula is threaded from a single entry point, reducing trauma and allowing precise placement at the correct tissue depth
• Conservative volume: Less is more in the tear trough; overfilling is a more common cause of adverse outcomes than underfilling
• MD supervision: All injectable treatments at Maison Zolara are performed by our RN clinicians under the oversight of our on-staff Medical Director

What if something needs correction? Juvéderm® Volbella® XC is fully reversible. Hyaluronidase, an enzyme that dissolves hyaluronic acid, can be injected to rapidly break down the filler if there is a Tyndall effect, asymmetry, or any other outcome that warrants correction. This is one of the key reasons many clinicians — and patients — prefer HA filler over non-reversible alternatives for the undereye zone.

A 2015 review in Clinical Plastic Surgery documented the multifactorial nature of under-eye dark circles and affirmed filler-based correction as an evidence-supported approach when anatomy is carefully assessed ↗.

Likely a Good Candidate

• Hollowing or shadowing beneath the eyes due to volume loss
• Fatigue or aged appearance that concealer does not address
• Generally healthy; no active skin infections in the treatment area
• Realistic expectations — subtle, natural-looking improvement
• Not pregnant or breastfeeding
• Willing to complete a consultation first

May Need a Different Approach

• Significant under-eye puffiness caused by fat pad prolapse (a structural issue filler cannot correct — surgical evaluation may be more appropriate)
• Dark circles caused primarily by pigmentation rather than volume loss (laser or topical treatments may be more effective)
• History of severe allergic reactions to HA products
• Active cold sore outbreak (reschedule)
• Recent dental surgery (wait 2 weeks minimum due to infection risk)

The tear trough is a groove that forms where the lower eyelid meets the cheek. It deepens as the sub-orbicularis oculi fat (SOOF) and malar fat pads diminish with age — a process that can begin as early as the mid-twenties ↗. The resulting hollow creates a dark shadow that even good concealer cannot fully correct, because the underlying cause is structural — volume loss, not pigmentation.

Dermal filler placed in the tear trough adds back lost volume beneath the skin. For HA filler, the product is injected into the deep tissue plane — ideally in the preperiosteal or sub-orbicularis plane — where it integrates with surrounding tissue and provides support without visible surface changes ↗. The shadow lightens because the structural deficit has been addressed at its source.

PRF works differently: a small blood draw is centrifuged to concentrate platelets and growth factors, which are then injected to stimulate collagen production and tissue regeneration over 4–8 weeks ↗.

Step 1 — Free Consultation

We assess your tear trough anatomy, discuss your goals, and determine whether HA filler, PRF, or a combination is appropriate. We review your medical history including any blood thinners, dental procedures, or prior filler treatments. No commitment required.

Step 2 — Day of Treatment

Topical numbing cream is applied for 20–30 minutes. Volbella XC also contains lidocaine for additional comfort during injection. The cannula entry point is marked, and filler is placed with precise, slow delivery — the full treatment takes approximately 20–30 minutes.

Step 3 — Immediate Post-Treatment

Mild swelling and occasional light bruising at the cannula entry point are normal and typically resolve within 3–5 days. We provide cold compresses and aftercare instructions before you leave. You can return to most normal activities the same day.

Step 4 — Results & Follow-Up

The result is visible immediately, though final results are best assessed after 2 weeks once all swelling has resolved. A touch-up consultation at 2 weeks is available. Full follow-up at 6–12 months to assess longevity and discuss retreatment.

First 48 Hours

• Keep the area clean and do not apply pressure to the treated zone
• Sleep on your back with your head slightly elevated if possible
• Avoid strenuous exercise, saunas, steam rooms, and hot yoga for 24–48 hours
• Do not receive facial massage or microneedling for 2 weeks
• Avoid alcohol for 24 hours (increases bruising risk)
• Apply cool (not ice-cold) compresses to reduce swelling

What's Normal vs. What to Report

Normal: Mild puffiness, light bruising at entry point, slight firmness in the treated area for a few days Call us if you notice: Significant asymmetry after 2 weeks, any blanching or white discoloration during treatment (sign of vascular compromise — very rare but should be reported immediately), blue-grey skin discoloration after swelling resolves

Per syringe · Final pricing confirmed at consultation · Most tear trough treatments require 0.5–1 syringe per side

Maison Circle membership provides reduced pricing across all injectable and device services at Maison Zolara. Ask about membership at your consultation. You can also manage appointments and track your treatment history through the Zolara Care app.

At Maison Zolara, we take a two-option approach: if you want an immediate result that can be dissolved if needed, Juvéderm® Volbella® XC is our hyaluronic acid filler of choice for the periorbital region. If you prefer a fully autologous option that uses your own biology, PRF (platelet-rich fibrin) offers a gradual, natural-appearing improvement with no synthetic material. A complimentary consultation helps us identify which — or which combination — is right for your anatomy and goals.

Juvéderm® Volbella® XC (HA Filler)

Best for: Moderate-to-significant volume loss; patients who want immediate, visible correction and the option of reversal

• Immediate result visible at appointment
• Fully reversible with hyaluronidase enzyme
• Results typically last 9–12 months or longer
• FDA-approved hyaluronic acid — same HA your body produces naturally
• Placed with a fine cannula to minimize bruising
• Mild swelling resolves in 3–5 days

PRF (Platelet-Rich Fibrin)

Best for: Patients seeking a fully autologous approach; mild hollowing; combination with HA filler for a layered result

• Uses your own blood — zero synthetic material
• Gradual result develops over 4–8 weeks as collagen rebuilds
• Not reversible, but metabolizes naturally
• Series of 2–3 sessions typically recommended
• Lower bruising risk than needle-based HA filler
• Can be combined with HA filler for synergistic effect

Ultra-Thin Consistency

Volbella XC has the lowest viscosity in the Juvéderm family, making it specifically suited for thin, delicate periorbital tissue. Its soft, pliable texture integrates smoothly without creating lumps or the stiff feel associated with thicker fillers used in other facial zones.

Deep Tissue Placement

Proper technique places Volbella in the preperiosteal or sub-orbicularis plane — well below the skin surface. This depth is critical: placing filler too superficially in the thin undereye skin is the primary cause of the Tyndall effect (a blue-grey discoloration). Our cannula technique allows precise depth control.

Vycross® Cross-Linking Technology

Volbella uses Allergan's proprietary Vycross technology, which combines high- and low-molecular-weight hyaluronic acid chains to create a smooth, cohesive gel that resists degradation. This formulation is designed for longevity and softness in areas that require minimal lift force.

Juvéderm® Volbella® XC is a registered trademark of AbbVie/Allergan Aesthetics.

Maison Zolara is located at 4820 W Saginaw Hwy, Lansing, MI 48917 — on the west side of Lansing, easily accessible from across the greater area. We welcome patients from throughout the region seeking under eye filler treatments, including:

Holt, Okemos, East Lansing, Mason, DeWitt, Grand Ledge, Charlotte, St. Johns, and Williamston — as well as the broader mid-Michigan area within our 30-mile service radius.

Whether you're coming from East Lansing after work, driving in from Mason or Holt, or scheduling from Okemos, our team offers convenient weekday and Saturday appointments. Call us at (517) 881-0878 or book online to schedule your complimentary consultation.

Hours: Monday–Friday 9:00 AM – 7:00 PM · Saturday 9:00 AM – 5:00 PM Address: 4820 W Saginaw Hwy, Lansing, MI 48917

1. Sharad J. "Treatment of the tear trough and infraorbital hollow with hyaluronic acid fillers using both needle and cannula." Dermatologic Therapy. 2020 May;33(3):e13353. doi: 10.1111/dth.13353. PMID: 32239729. https://pubmed.ncbi.nlm.nih.gov/32239729/

2. Liew S, Doreian S, Kunathathorn W, et al. "Lower Eyelid Dark Circles (Tear Trough and Lid-Cheek Junction): A Stepwise Assessment Framework." Aesthetic Surgery Journal. 2024 Jun 14;44(7):NP476–NP485. doi: 10.1093/asj/sjae058. PMID: 38489829. https://pubmed.ncbi.nlm.nih.gov/38489829/

3. Nanda S, Bansal S, Lakhani R. "Use of hyaluronic acid fillers in treatment of periorbital melanosis induced by tear trough deformity: Anatomical considerations, patient satisfaction, and management of complications." Journal of Cosmetic Dermatology. 2021 Oct;20(10):3181–3189. doi: 10.1111/jocd.14251. PMID: 34028173. https://pubmed.ncbi.nlm.nih.gov/34028173/

4. Rahbari S, Ohandjanians L, Cong A, et al. "Periocular Rejuvenation with PRF Gel." Facial Plastic Surgery. 2026 Apr 28. doi: 10.1055/a-2849-8705. PMID: 41991137. https://pubmed.ncbi.nlm.nih.gov/41991137/

5. Friedmann DP, Goldman MP. "Dark circles: etiology and management options." Clinics in Plastic Surgery. 2015 Jan;42(1):33–50. doi: 10.1016/j.cps.2014.08.007. PMID: 25440739. https://pubmed.ncbi.nlm.nih.gov/25440739/

Page Disclaimer: The information on this page is provided for educational purposes only and does not constitute medical advice. Clinical references are sourced from peer-reviewed research and named institutions as cited below. Individual results vary. Consult a qualified healthcare provider before beginning any treatment.

The Medical Director provides clinical oversight of treatments performed at this practice. The Medical Director does not author, review, or endorse website content.

Juvéderm® Volbella® XC is a registered trademark of AbbVie/Allergan Aesthetics.